Elizabeth Czerepak - 18 May 2022 Form 4 Insider Report for Sorrento Therapeutics, Inc.

Role
EVP & Chief Financial Officer
Signature
/s/ Henry Ji, Ph.D., as attorney-in-fact
Issuer symbol
N/A
Transactions as of
18 May 2022
Net transactions value
$0
Form type
4
Filing time
20 May 2022, 17:14:46 UTC
Previous filing
06 May 2022
Next filing
15 Nov 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SRNEQ Stock Option (right to buy) Award $0 +350,000 $0.000000 350,000 18 May 2022 Common Stock 350,000 $1.51 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/4th of the original number of shares subject to the option shall vest on May 18, 2023, and 1/48th of the original number of shares subject to the option shall vest on a monthly basis thereafter, subject to the Reporting Person's continued service to the Issuer through each such vesting date.